Effect of center use of pre-transplant hepatocellular carcinoma ablation therapy on liver transplant recipient survival

被引：0
|
作者：
Freeman, Richard [1 ]
Steffick, Diane E. [2 ]
Guidinger, Mary K. [2 ]
Wolfe, Robert A. [2 ]
Merion, Robert M. [3 ]
机构：
[1] Tufts Univ New England Med Ctr, Boston, MA USA
[2] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：383 / 383
页数：1
相关论文
共 50 条
  • [1] The effect of pre-transplant ablation therapy on post-transplant outcome in liver recipients with hepatocellular carcinoma
    Edwards, Erick B.
    Harper, Ann M.
    Freeman, Richard B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 267 - 267
  • [2] PRE-TRANSPLANT LIVER DIRECTED THERAPY FOR HEPATOCELLULAR CARCINOMA IMPROVES POST-TRANSPLANT SURVIVAL.
    Mangus, Richard S.
    Maluccio, Mary
    Kumar, Hari
    Fridell, Jonathan A.
    Vianna, Rodrigo M.
    Jones, Daniel T.
    Tector, A. Joseph
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S218 - S218
  • [3] The Prognostic Impact of Pre-transplant BMI on Survival Rate of Liver Transplant Recipients with Hepatocellular Carcinoma
    Al Taii, Haider
    Esfeh, Jamak Modaresi
    Lopez, Rocio
    Romero-Marrero, Carlos
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S352 - S352
  • [4] Hepatocellular carcinoma (HCC) recurrence following liver transplant correlates with the severity of pre-transplant recipient immune dysfunction
    Prakash, G. S.
    Panayotova, G. G.
    Simonishvili, S.
    Qin, Y.
    Ayorinde, T.
    Jin, L.
    Minze, L. J.
    Corkrean, J.
    Sharma, A.
    Paterno, F.
    Brown, L.
    Amin, A.
    Liu, D.
    Ghobrial, R. M.
    Guarrera, J. V.
    Lunsford, K. E.
    [J]. TRANSPLANTATION, 2022, 106 (8S) : 59 - 60
  • [5] Survival impact of pre-transplant local treatments in liver transplant recipients with BCLC stage A hepatocellular carcinoma
    Hsu, Po-Jung
    Wu, Szu-Yuan
    Chen, Wan-Ming
    Chang, Yu-Cheng
    Chou, Ta-Chun
    Chiang, Ming-Feng
    Lee, Ming-Che
    Soong, Ruey-Shyang
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (07): : 3555 - 3564
  • [6] THE EFFECT OF PRE-TRANSPLANT IMMUNOTHERAPY ON THE PROGNOSIS OF TRANSPLANT RECEIPENTS WITH HEPATOCELLULAR CARCINOMA
    Xing, Hao
    Li, Li
    Zhang, Quanbao
    Li, Jianhua
    Ma, Ensi
    Pei, Jiahao
    Xue, Hongyuan
    Zhu, Ningqi
    Shen, Conghuan
    Ma, Zhenyu
    Li, Ruidong
    Tao, Yifeng
    Wang, Zhengxin
    [J]. HEPATOLOGY, 2022, 76 : S534 - S535
  • [7] Pre-transplant adjuvant therapy for hepatocellular carcinoma results in a survival disadvantage.
    Cavazzoni, E
    Meehan, MD
    Shackleton, C
    Sher, L
    Vierling, J
    Nissen, N
    Martin, P
    Poordad, F
    Tran, T
    Ayoub, W
    Colquhoun, S
    [J]. HEPATOLOGY, 2003, 38 (04) : 758A - 759A
  • [8] Use of Metformin in Liver Transplant Recipient With Hepatocellular Carcinoma
    Choi, J.
    Lee, K.
    Rhu, J.
    Gil, E.
    Na, B.
    Oh, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 750 - 750
  • [9] Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
    Zucker, Kelly M.
    Gomez, Paul A.
    Kezirian, Olivia
    Mehta, Shivang
    [J]. GASTROENTEROLOGY RESEARCH, 2021, 14 (03) : 190 - 193
  • [10] PRE-TRANSPLANT FACTORS INFLUENCING RATES OF HEPATOCELLULAR CARCINOMA RECURRENCE IN LIVER TRANSPLANT RECIPIENTS
    Zucker, Kelly
    Gomez, Paul
    Kezirian, Olivia
    Fallon, Michael B.
    Mehta, Shivang
    [J]. HEPATOLOGY, 2020, 72 : 648A - 648A
12345